Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Klimberg, V. S.
Right arrow Articles by Westbrook, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klimberg, V. S.
Right arrow Articles by Westbrook, K. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*METHOTREXATE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Glutamine Facilitates Chemotherapy While Reducing Toxicity

V. Suzanne Klimberg, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Emmanuel Nwokedi, BS

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Laura F. Hutchins, MD

Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Alex A. Pappas, MD

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Nicholas P. Lang, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

J. Ralph Btoadwater, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Raymond C. Read, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Kent C. Westbrook, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, The John L. McClellan Memorial Veteran's Administration Hospital, Little Rock, Arkansas

Dose intensification of chemotherapy is thought to increase survival. With recent advances in hemopoietic cell modulators such as granulocyte colony stimulating factor, the limiting toxicity of intensifying chemotherapeutic regimens has become the severity of the associated enterocolitis. In animal models, glutamine protects the host from methotrexate-induced enterocolitis. This study evaluates the effects of a glutamine-supplemented diet on the tumoricidal effectiveness of methotrexate. Sarcoma-bearing Fisher 344 rats (n = 30) were pair-fed an isocaloric elemental diet containing 1% glutamine or an isonitrogenous amount of glycine beginning on day 25 of the study. Rats from each group received two intraperitoneal injections of methotrexate (5 mg/kg) or saline on days 26 and 33 of the study. On day 40, rats were killed, tumor volume and weight were recorded, and tumor glutaminase activity and tumor morphometrics were measured. Blood was taken for arterial glutamine content, complete blood count, and blood culture. The gut was processed for glutaminase activity and synthesis phase of the deoxyribonucleic acid. In rats receiving methotrexate, the tumor volume loss was nearly doubled when glutamine was added to the diet. Significant differences in tumor glutaminase activity and morphometrics were not detected. The toxicity to the host was ameliorated. Significantly increased synthesis phase of deoxyribonucleic acid of the whole jejunum, decreased bacteremia, "sepsis," and mortality were demonstrated. Glutamine supplementation enhances the tumoricidal effectiveness of methotrexate while reducing its morbidity and mortality in this sarcoma rat model. (Journal of Parenteral and Enteral Nutrition 16:83S-87S, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 6 Suppl, 83S-87S (1992)
DOI: 10.1177/014860719201600609


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nutr Clin PractHome page
C. Ford and J. B. Pietsch
Home Enteral Tube Feeding in Children After Chemotherapy or Bone Marrow Transplantation
Nutr Clin Pract, February 1, 1999; 14(1): 19 - 22.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
Y. Cao, Z. Feng, A. Hoos, and V. S. Klimberg
Glutamine Enhances Gut Glutathione Production
JPEN J Parenter Enteral Nutr, July 1, 1998; 22(4): 224 - 227.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
W. W. Souba
Total Parenteral Nutrition With Glutamine in Bone Marrow Transplantation and Other Clinical Applications
JPEN J Parenter Enteral Nutr, September 1, 1993; 17(5): 403 - 403.
[PDF]